InvestorsHub Logo
Followers 21
Posts 154
Boards Moderated 0
Alias Born 05/27/2008

Re: cabel post# 194854

Monday, 08/28/2017 9:44:37 AM

Monday, August 28, 2017 9:44:37 AM

Post# of 403035
Very relieved to hear today's news that prurisol remains on schedule and obviously no major safety concerns with increased doses.

2 phase 2 trials to be completed by end of 2017. Hopefully, with additional kevetrin Ovarian cancer trial site, that will also be completed by end of 2017.

Progress is being made, patience will be rewarded.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News